Clinical Report: Advancing Stroke Care with Vagus Nerve Stimulation

Overview

WashU Medicine has introduced vagus nerve stimulation (VNS) as an innovative adjunct to rehabilitation for chronic stroke patients, aiming to enhance motor recovery. This approach has shown promise in breaking through previously considered recovery plateaus, offering renewed hope for patients.

Background

Chronic stroke patients often face significant challenges in regaining mobility and strength due to the diminishing effectiveness of rehabilitation as the brain's plasticity declines. The integration of VNS into stroke rehabilitation represents a significant advancement in neurorehabilitation, potentially extending recovery opportunities. This innovative approach is currently being implemented exclusively at Barnes-Jewish Hospital by WashU Medicine specialists.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

• VNS has been FDA-approved for epilepsy and depression and is now being explored for chronic stroke rehabilitation.
• WashU Medicine has developed therapies based on the understanding of motor control signals in the brain, leading to advanced rehabilitation techniques.
• The Neurolutions IpsiHand is the first FDA-cleared device utilizing brain-computer interface technology for stroke rehabilitation.
• Patients typically undergo intensive outpatient therapy for six weeks, receiving 500-800 VNS stimulations per session to enhance motor learning.
• VNS stimulates the vagus nerve, releasing neuromodulators that may increase brain plasticity and support recovery.

Clinical Implications

Healthcare professionals should consider VNS as a potential adjunct therapy for carefully selected chronic stroke patients, particularly those who have plateaued in their recovery. Collaboration with multidisciplinary teams is essential to tailor rehabilitation strategies that incorporate innovative technologies like VNS.

Conclusion

The use of VNS in conjunction with traditional rehabilitation therapies offers a promising avenue for improving outcomes in chronic stroke patients. Continued research and clinical application may further validate its efficacy and expand treatment options.

Related Resources & Content

1. Barnes-Jewish Hospital, Source, 2023 -- Restoring Movement, Reclaiming Lives: Advancing Brachial Plexus Injury Care at Barnes-Jewish Hospital
2. Barnes-Jewish Hospital, Source, 2023 -- Making Waves - Barnes-Jewish Hospital first to offer high intensity focused ultrasound for patients with ET
3. Barnes-Jewish Hospital, Source, 2023 -- Early Intervention & Multidisciplinary Care: Key to Positive Outcomes for Heart Failure Patients at Barnes-Jewish Hospital
4. AHA/ASA Guideline, 2016 -- Guidelines for Adult Stroke Rehabilitation and Recovery
5. PubMed, 2021 -- Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial
6. barnes-jewish — Washington University Vascular Surgeons at Barnes-Jewish Hospital Deliver Outstanding Care to Patients
7. AHA/ASA Guideline
8. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial - PubMed
9. Is vagus nerve stimulation added to rehabilitation more effective than rehabilitation alone in the recovery of upper limb function and activity after stroke? | Cochrane